Suggestions
Alastair Kilgour
Founder Parkwalk Advisors
Alastair Kilgour is an experienced investment professional and board member with a significant role at Mogrify, a biopharmaceutical company focused on developing in vivo reprogramming therapies. Here's a comprehensive overview of his profile:
Professional Background
Alastair Kilgour serves as an Investment Director at Mogrify, representing Parkwalk Advisors, a company he co-founded in 2009.1 His role at Mogrify is crucial in overseeing investments and providing strategic guidance to the company.
Experience and Expertise
Financial and Investment Background: Kilgour has an extensive career in finance and investment:
His expertise lies in analyzing and advising both private and public companies on strategy, development, fund-raising, and exits.14
Current Roles:
- Chief Investment Officer at Parkwalk Advisors6
- Oversees the investment process at Parkwalk1
- Sits on various portfolio company boards, including Congenica, PhoreMost, PredictImmune, Aqdot, and Mirriad1
Involvement with Mogrify
Kilgour plays a significant role in Mogrify's growth and development:
- Participated in Mogrify's Series A financing, which raised a total of $46 million USD2
- Provides strategic input and investment oversight as an Investor Director1
Recent Career Developments
As of June 25, 2024, Alastair Kilgour announced his last day in a full-time role, suggesting a transition to new challenges or a different phase in his career.3
Alastair Kilgour's extensive experience in investment and advisory roles, combined with his position at Mogrify, demonstrates his significant influence in the life sciences and biotechnology investment landscape.
